Financial Post
🏢 Postmedia
Aug 4, 2026
· 1 min read
AI Analyzed
○ Unverifiable
View full audit trail →
Moderna Begins Human Trial of Experimental Ebola Vaccine in Canada
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.315 · RIGHT
Ensemble
0.158 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.022
4,491 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
Moderna Inc. has begun testing an experimental Ebola vaccine in people, marking the second candidate to enter clinical trials against the strain driving the deadliest Ebola outbreak in Democratic Republic of Congo’s history.
Read full article at Financial Post ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
pending
Aug 4, 2026
📰
🔒 Unlock — Starter+
4 outlets covered this story
Side-by-side comparison · bias by outlet · framing analysis